NCT05965830

Brief Summary

Background of the study: Increased work of breathing, potentially leading to respiratory insufficiency, resulting in the need of (non-) invasive respiratory support is the most common observed problem in the neonatal - and pediatric intensive care unit (NICU/PICU). The diaphragm is the main respiratory muscle. Currently there is not an established technique accessible to observe the (clinical) function of the diaphragm and its role in respiratory insufficiency. New non-invasive modalities are promising, such as transcutaneous diaphragm electromyography (dEMG) and diaphragm ultrasound (dUS). Objective of the study: Our objective is to assess the association between transcutaneous diaphragm electromyography (dEMG) and diaphragm ultrasound (dUS) in the PICU population. Study design: Single center pilot study Study population: The study population consists of children between 0-12 months, admitted to the PICU of the Leiden University Medical Center, with invasive respiratory support. Primary study parameters/outcome of the study: Primary endpoint is to evaluate the association between dEMG and dUS measurements in the PICU population.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 20, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 28, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

November 25, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

March 18, 2025

Status Verified

March 1, 2025

Enrollment Period

1.9 years

First QC Date

July 20, 2023

Last Update Submit

March 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Association between dEMG amplitude and dUS diaphragm thickening fraction and dEMG tonic activity and diaphragm thickness

    Evaluation of the association between dEMG and dUS measurements in the PICU population with invasive respiratory support. Pearson's correlation coefficient is used to quantify the correlation between dEMG and dUS variables.

    1 year

Secondary Outcomes (1)

  • Assessment of patient specific values of dEMG and dUS

    1 year

Study Arms (1)

Study cohort

The study population consists of clinically stable infants or pediatric patients up to 12 months of age admitted to the PICU.

Device: Diaphragm ultrasound

Interventions

A single, simultaneous assessment of the diaphragm muscle functioning through dEMG and dUS at the time of spontaneous breathing.

Also known as: transcutaneous diaphragm EMG
Study cohort

Eligibility Criteria

Age0 Months - 12 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of clinically stable infants or pediatric patients up to 12 months of age admitted to the PICU.

You may qualify if:

  • Specific patients cohort PICU:
  • pediatric patients with invasive respiratory support comply with the extubation readiness test (ERT) criteria
  • No spontaneous breathing for the duration of the assessment
  • Written parenteral informed consent (IC)
  • A patient can only participate once

You may not qualify if:

  • Unilateral diaphragm paresis diagnosed by ultrasound
  • Congenital malformations not compatible with dEMG
  • Need of cardiac pacing
  • Congenital muscle atrophy disorder
  • Clinical instability requiring frequent interventions by the nursing staff that may interfere with the measurements
  • The attending physician considers the patient to be too vulnerable to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pediatric Intensive Care Unit

Leiden, Netherlands

RECRUITING

Central Study Contacts

Sabien Heisterkamp

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pediatric intensivist

Study Record Dates

First Submitted

July 20, 2023

First Posted

July 28, 2023

Study Start

November 25, 2023

Primary Completion

October 1, 2025

Study Completion

November 1, 2025

Last Updated

March 18, 2025

Record last verified: 2025-03

Locations